Biopharma in the Line of Fire in Federal Budget Battle
By Mari Serebrov
Monday, April 18, 2011
WASHINGTON The biopharmaceutical industry could be one of the casualties as Congress and the president prepare the field for the battle of the 2012 budget.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.